The “FeAST” trial has proved that there were highly significant reductions in all‐cause mortality and in combined death plus nonfatal myocardial infarction and stroke in association with iron reduction therapy. 128 However, iron supplementation appears to be crucial as a therapy for CKD with anemia that is associated with VC.
← all excerpts
Vascular calcification: Molecular mechanisms and therapeutic interventions.
1
—
—